Cargando…
Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study
BACKGROUND: The J-Land 3S trial demonstrated that landiolol is effective and tolerated for treating sepsis-related tachyarrhythmias. Patient characteristics (e.g. baseline heart rate [HR], type of tachyarrhythmia, and concomitant disorders) may impact the outcomes of landiolol therapy. We performed...
Autores principales: | Matsuda, Naoyuki, Nishida, Osamu, Taniguchi, Takumi, Okajima, Masaki, Morimatsu, Hiroshi, Ogura, Hiroshi, Yamada, Yoshitsugu, Nagano, Tetsuji, Ichikawa, Akira, Kakihana, Yasuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700908/ https://www.ncbi.nlm.nih.gov/pubmed/33294804 http://dx.doi.org/10.1016/j.eclinm.2020.100571 |
Ejemplares similares
-
Efficacy and Safety of Landiolol in Patients With Ventricular Tachyarrhythmias With or Without Renal Impairment ― Subanalysis of the J-Land II Study ―
por: Shiga, Tsuyoshi, et al.
Publicado: (2020) -
Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies
por: Ashida, Atsuko, et al.
Publicado: (2021) -
Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
por: Gangl, Clemens, et al.
Publicado: (2022) -
Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia
por: Kiuchi, Shunsuke, et al.
Publicado: (2017) -
Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series
por: Ditali, Valentina, et al.
Publicado: (2021)